Marie Rowland
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marie Rowland has a total of 1 co-authors. Here are the top co-authors by number of shared publications:
- Shaheen Emmanuel Lakhan
Bioscience, Global Neuroscience Initiative Foundation, Miami, USA
1 shared publication
Latest Publications
- Open Access
- 4 December 2009
- Published by Springer Nature in BMC Neurology
- Vol. 9 (1) , 59
Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review
Cannabis therapy has been considered an effective treatment for spasticity, although clinical reports of symptom reduction in multiple sclerosis (MS) describe mixed outcomes. Recently introduced therapies of combined Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) extracts have potential for symptom relief with the possibility of reducing intoxication and other side effects. Although several past reviews have suggested that cannabinoid therapy provides a therapeutic benefit for symptoms of MS, none have presented a methodical investigation of newer cannabinoid treatments in MS-related spasticity. The purpose of the present review was to systematically evaluate the effectiveness of combined THC and CBD extracts on MS-related spasticity in order to increase understanding of the treatment's potential effectiveness, safety and limitations.
- 4 December 2009
- Published by Springer Nature in BMC Neurology
- Vol. 9 (1) , 59
Open AccessWhole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review
Cannabis therapy has been considered an effective treatment for spasticity, although clinical reports of symptom reduction in multiple sclerosis (MS) describe mixed outcomes. Recently introduced therapies of combined Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) extracts have potential for symptom relief with the possibility of reducing intoxication and other side effects. Although several past reviews have suggested that cannabinoid therapy provides a therapeutic benefit for symptoms of MS, none have presented a methodical investigation of newer cannabinoid treatments in MS-related spasticity. The purpose of the present review was to systematically evaluate the effectiveness of combined THC and CBD extracts on MS-related spasticity in order to increase understanding of the treatment's potential effectiveness, safety and limitations.